The Fox Chase Chemical Diversity Center Announces it Has Licensed a Platform to VeraDermics, Inc. for the Treatment of Molluscum Contagiosum and Related Pox-Virus Diseases
Doylestown, PA. August 24, 2022 – FCCDC is pleased to announce that a small-molecule pox-virus platform it has created together with Prof. Robert Ricciardi of the University of Pennsylvania has been licensed to VeraDermics, Inc. for the treatment of Molluscum contagiosum and related pox-virus diseases. See the official press release here.